EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2D 1 H sLASER Long‐ TE and 3D 31 P Chemical Shift Imaging at 3 T for Monitoring Fasting‐Induced Changes in Brain Tumor Tissue

Seyma Alcicek iD, Iris Divé, Dennis C Thomas, Vincent Prinz, Marie-Thérèse Forster, Marcus Czabanka, Katharina J Weber, Joachim P Steinbach, Michael W Ronellenfitsch, Elke Hattingen, Ulrich Pilatus, Katharina J Wenger

Journal of Magnetic Resonance Imaging · 2025-01 · 61 (1) · 426-438

DOI: 10.1002/jmri.29422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 09.05.2024. Verfasst von Seyma Alcicek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany. Hauptthemen laut MEDLINE: Brain Neoplasms, Fasting, Glioma, Phantoms, Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe), Else Kröner-Fresenius-Stiftung (EKFS), LOEWE grant within the CePTER Consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence suggests that fasting could play a key role in cancer treatment. Its metabolic effects on gliomas require further investigation.

Purpose

To design a multi‐voxel 1 H/ 31 P MR‐spectroscopic imaging (MRSI) protocol for noninvasive metabolic monitoring of cerebral, fasting‐induced changes on an individual patient/tumor level, and to assess its technical reliability/reproducibility. Study Type Prospective. Population MRS phantom. Twenty‐two patients (mean age = 61, 6 female) with suspected WHO grade II‐IV glioma examined before and after 72‐hour‐fasting prior to biopsy/resection. Field Strength/Sequence 3‐T, 1 H decoupled 3D 31 P MRSI, 2D 1 H sLASER MRSI at an echo time of 144 msec, 2D 1 H MRSI (as water reference), T1‐weighted, T1‐weighted contrast‐enhanced, T2‐weighted, and FLAIR. sLASER and PRESS sequences were used for phantom measurements. Assessment Phantom measurements and spectral simulations were performed with various echo‐times for protocol optimization. In vivo spectral analyses were conducted using LCModel and AMARES, obtaining quality/fitting parameters (linewidth, signal‐to‐noise‐ratio, and uncertainty measures of fitting) and metabolite intensities. The volume of glioma sub‐regions was calculated and correlated with MRS findings. Ex‐vivo spectra of necrotic tumor tissues were obtained using high‐resolution magic‐angle spinning (HR‐MAS) technique. Statistical Tests Wilcoxon signed‐rank test, Bland–Altman plots, and coefficient of variation were used for repeatability analysis of quality/fitting parameters and metabolite concentrations. Spearman ρ correlation for the concentration of ketone bodies with volumes of glioma sub‐regions was determined. A P ‐value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsFastingGliomaPhantoms, ImagingMagnetic Resonance ImagingImaging, Three-DimensionalHumansFemaleMiddle AgedProspective StudiesMaleReproducibility of ResultsAgedMagnetic Resonance SpectroscopyAdultBrain

Stichwörter der Autor:innen

1H sLASER long‐TEMR spectroscopyfastinggliomaketone bodies

Autor:innen und Institutionen

  • Institute of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany.
  • University Cancer Center Frankfurt (UCT), Frankfurt/Main, Germany.
  • Frankfurt Cancer Institute (FCI), Frankfurt/Main, Germany.
  • German Cancer Research Center (DKFZ) Heidelberg, Germany and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany.
  • Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany.
  • Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt/Main, Germany.

ORCID-Profile: Seyma Alcicek

Förderung

  • Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe)
  • Else Kröner-Fresenius-Stiftung (EKFS)
  • LOEWE grant within the CePTER Consortium
  • Deutsche Krebshilfe

Zitieren

APA

Alcicek, S., Divé, I., Thomas, D. C., Prinz, V., Forster, M. T., Czabanka, M., Weber, K. J., Steinbach, J. P., Ronellenfitsch, M. W., Hattingen, E., Pilatus, U., & Wenger, K. J. (2025). 2D 1 H sLASER Long‐ TE and 3D 31 P Chemical Shift Imaging at 3 T for Monitoring Fasting‐Induced Changes in Brain Tumor Tissue. Journal of Magnetic Resonance Imaging, 61(1), 426-438. https://doi.org/10.1002/jmri.29422

Vancouver

Alcicek S, Divé I, Thomas DC, Prinz V, Forster MT, Czabanka M, et al. 2D 1 H sLASER Long‐ TE and 3D 31 P Chemical Shift Imaging at 3 T for Monitoring Fasting‐Induced Changes in Brain Tumor Tissue. Journal of Magnetic Resonance Imaging. 2025;61(1):426-438. doi:10.1002/jmri.29422

BibTeX
@article{Alcicek2025,
  author = {Alcicek, Seyma and Divé, Iris and Thomas, Dennis C and Prinz, Vincent and Forster, Marie-Thérèse and Czabanka, Marcus and Weber, Katharina J and Steinbach, Joachim P and Ronellenfitsch, Michael W and Hattingen, Elke and Pilatus, Ulrich and Wenger, Katharina J},
  title = {2D 1 H sLASER Long‐ TE and 3D 31 P Chemical Shift Imaging at 3 T for Monitoring Fasting‐Induced Changes in Brain Tumor Tissue},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  volume = {61},
  number = {1},
  pages = {426--438},
  doi = {10.1002/jmri.29422}
}
Kostenlos starten →